The King Faisal Specialist Hospital and Research Centre is tertiary referral hospital in Riyadh, the capital city of Saudi Arabia.

During the past decade, King Faisal Specialist Hospital & Research Centre; Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "King Faisal Specialist Hospital & Research Centre; Oncology" are "Breast Neoplasms" (1 trials), "Hemophilia A" (1 trials), "Hepatitis B, Chronic" (1 trials), "Rectal Adenocarcinoma" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "King Faisal Specialist Hospital & Research Centre; Oncology" in a lesser frequency.

Most popular intervention types in "King Faisal Specialist Hospital & Research Centre; Oncology" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Docetaxel" (1 trials), "Emicizumab" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "King Faisal Specialist Hospital & Research Centre; Oncology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "King Faisal Specialist Hospital & Research Centre; Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in King Faisal Specialist Hospital & Research Centre; Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in King Faisal Specialist Hospital & Research Centre; Oncology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".